差异化甲状腺癌患者的动态风险评估
Erika Abelleira1, Fernando Jerkovich2
1Division of Endocrinology, Hospital de Clínicas José de San Martín (UBA), University of Buenos Aires, Córdoba 2351, 5th floor, Buenos Aires, C 1120, Argentina. erikaabelleira@hotmail.com.
Reviews in endocrine & metabolic disorders
|November 28, 2023
概括
对差异化甲状腺癌 (DTC) 的个体化风险分层优化了患者管理. 动态风险评估指导治疗决策,避免过度治疗,并确保针对高风险病例提供有针对性的干预措施.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 手术瘤学手术瘤学
背景情况:
- 分化甲状腺癌 (DTC) 管理需要个性化策略.
- 风险分层对于识别患有持续性或复发性疾病的患者至关重要.
研究的目的:
- 审查DTC中关于动态风险评估的当前信息.
- 概述基于动态风险分层的建议管理.
主要方法:
- 对有关DTC复发动态风险的现有信息的文献综述.
- 对手术前,手术后和长期随访情景的风险分层分析.
主要成果:
- 最初的风险分层指导患者立即管理.
- 动态风险评估,考虑治疗反应,告知残留物除和长期护理.
- 这种方法可以防止低风险患者不必要的治疗,并为高风险患者提供有针对性的治疗.
结论:
- 个性化,动态的风险分层对于最佳的DTC管理至关重要.
- 这一战略平衡了避免过度治疗和提供必要的干预措施.
- 未来的瘤生物学研究和前性研究将提高复发预测的准确性.
相关概念视频
Radiological Investigation I: X-ray and CT
245
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
245
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130


